Loading clinical trials...
Loading clinical trials...
The Effect of Recombinant Human Erythropoietin on the Postoperative Neurologic Outcome in Pediatric Moyamoya Disease Patients - A Double Blind Randomized Controlled Trial
Conditions
Interventions
erythropoietin
Normal saline
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
April 8, 2019
Primary Completion Date
December 31, 2023
Completion Date
December 31, 2023
Last Updated
November 22, 2023
NCT03986021
NCT07185022
NCT03153683
NCT07144930
NCT07324278
NCT03268824
Lead Sponsor
Seoul National University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions